ProVirTM: Viral Antigen Bank
Recombinant antigens are key reagents in infectious disease research, which are widely used in therapeutic antibody and vaccine development. Sino Biological has independently developed the world's largest recombinant viral antigen collection, ProVirTM, which features an exclusive coronavirus catalog, a comprehensive collection of influenza antigens, and many other hard-to-find viral proteins such as Zika, RSV, Ebola, and Cytomegalovirus.
The ProVirTM viral antigen bank includes over 1,000 antigens from 90 virus types/subtypes and 350 strains, and has been widely used worldwide in infectious disease research, therapeutic antibody evaluation, immunodiagnostic assay, and vaccine development.
Recombinant SARS-CoV-2 Variants
Recombinant Antigens for Influenza Vaccine Strains
Recombinant Antigens for More Infectious Visuses, like Ebola, Zika, RSV, and HPV.
